Acadia Pharmaceuticals | ACAD - EPS Earnings Per Share


Acadia Pharmaceuticals reported $0.31 in EPS Earnings Per Share for its fiscal quarter ending in September of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2026 0.31 0.13 0.42 Nov/04
FY2026Q2 Jun/2026 0.18 0.06 0.16 Aug/04
FY2026Q1 Mar/2026 0.02 0.07 0.11 May/06
FY2025Q4 Dec/2025 1.60 0.14 0.86 Feb/25
FY2025Q3 Sep/2025 0.42 0.14 0.20 Nov/05




Eps Change Date
Acadia Pharmaceuticals USD 0.31 0.13 Sep/2026
ALKERMES USD 0.09 0.09 Sep/2026
Alnylam Pharmaceuticals USD 16.26 14.42 Sep/2026
Biogen USD 2.62 0.98 Sep/2026
BioMarin Pharmaceutical USD 0.23 0.97 Sep/2026
Bristol-Myers Squibb USD 1.35 0.69 Sep/2026
Cara Therapeutics USD -0.72 0.14 Mar/2026
Corcept Therapeutics USD 1.01 0.65 Sep/2026
Cytokinetics USD -1.37 0.13 Sep/2026
Eisai JPY 41.47 23.24 Sep/2026
Eli Lilly USD 7.48 0.9 Sep/2026
Incyte USD -3.6 6.69 Sep/2026
J&J USD 2.7 0.2 Sep/2026
Moderna USD 0.38 2.35 Sep/2026
Neurocrine Biosciences USD 3.29 0.44 Sep/2026
Pfizer USD 0.87 0.1 Sep/2026
Prothena USD -0.36 0.96 Jun/2026
PTC Therapeutics USD -0.62 1.54 Sep/2026
Sarepta Therapeutics USD 0.13 0.51 Sep/2026
Ultragenyx Pharmaceutical USD -1.16 0.26 Sep/2026
Vanda Pharmaceuticals USD -0.09 0 Dec/2024
Vertex Pharmaceuticals USD 4.76 0.03 Sep/2026